<SEC-DOCUMENT>0000899243-20-035195-index.html : 20201228
<SEC-HEADER>0000899243-20-035195.hdr.sgml : 20201228
<ACCEPTANCE-DATETIME>20201228163011
ACCESSION NUMBER:		0000899243-20-035195
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20201222
FILED AS OF DATE:		20201228
DATE AS OF CHANGE:		20201228

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Martin Robert Daniel
		CENTRAL INDEX KEY:			0001509322

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13467
		FILM NUMBER:		201418656

	MAIL ADDRESS:	
		STREET 1:		C/O HEDGEPATH PHARMACEUTICALS, INC.
		STREET 2:		324 SOUTH HYDE PARK AVENUE, SUITE 350
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33606

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Inhibitor Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001042418
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				541641133
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		4830 W. KENNEDY BLVD.
		STREET 2:		SUITE 600
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33609
		BUSINESS PHONE:		(813) 766-2462

	MAIL ADDRESS:	
		STREET 1:		4830 W. KENNEDY BLVD.
		STREET 2:		SUITE 600
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HedgePath Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20130816

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COMMONWEALTH BIOTECHNOLOGIES INC
		DATE OF NAME CHANGE:	19970714
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>